CLEVELAND, March 2, 2016 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ (digital clinical) technologies, today announced tremendous response and interest in their entire platform of solutions, driven by the introduction of UX CTMS 360™.
"Interest in UX CTMS 360™, our latest software introduction, has attracted users to our full platform," said Scott DeMell, Vice President Sales, DATATRAK. "Our transformational CTMS product demonstrates the power of a comprehensive platform that is purpose built for clinical research. Clear data views, within and across trials, and industry-leading reporting capability delivers on the promise of technology to simplify clinical research."
DATATRAK was a Corporate Sponsor of SCOPE 2016 and featured Barbara Norris presenting 'Adoption and Implementation of Innovative Approaches' as part of the 'Clinical IT Strategy and Governance' program.
Book an appointment with DATATRAK to see UX CTMS 360™ and the full DATATRAK platform in action.
Join DATATRAK Thought Leaders:
Tweet: #Clinicaltrial leaders impressed with efficiency of DATATRAK platform http://ow.ly/YZPfH #eclinical
DATATRAK International is a worldwide technology and services company delivering Unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK offers a comprehensive solution on a single, unified platform. The Company delivers a complete portfolio of software products designed to accelerate the collection, analysis and submission of clinical trials. The DATATRAK ONE® software solution, deployed worldwide supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.